CELA2A: A Protein Involved in Calcium Ion Regulation and Potential Drug Target/biomarker

Target Name: CELA2A

NCBI ID: G63036

CELA2A

CELA2A: A Protein Involved in Calcium Ion Regulation and Potential Drug Target/biomarker

CELA2A (pe-1) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the calbindin family of proteins, which are involved in a variety of cellular processes, including signaling and tissue structure. One of the functions of calbindin is to regulate the levels of calcium ions in cells, which are important for many different cellular processes.

Recent studies have suggested that CELA2A may be a drug target or biomarker for a variety of diseases. For example, some researchers have found that high levels of CELA2A are associated with an increased risk of developing Alzheimer's disease, and that inhibiting CELA2A may be a potential treatment for this disease. Additionally, CELA2A has been shown to be involved in the development of certain types of cancer, and may be a useful biomarker for these diseases.

In addition to its potential as a drug target or biomarker, CELA2A is also of interest to researchers because of its structure and function. The calbindin family of proteins is characterized by a series of repetitive and evolutionally conserved domains, and CELA2A is no exception. It contains a single domain that is composed of a series of amino acids that are involved in the regulation of calcium ions.

The function of CELA2A is related to the regulation of calcium ions in cells. These ions are important for many different cellular processes, including muscle contractions, nerve signaling, and blood clotting. They are also involved in the regulation of many different cellular processes, including cell growth, differentiation, and inflammation. In addition, calcium ions are also involved in the regulation of the immune response and the production of antibodies.

One of the unique features of CELA2A is its ability to regulate calcium ions in cells at the level of the cell membrane. This is important for the regulation of many different cellular processes, including the signaling of neurons and the regulation of the immune response. CELA2A is also involved in the regulation of the production of reactive oxygen species (ROS), which are toxic to cells and can contribute to a variety of cellular diseases.

In conclusion, CELA2A is a protein that is expressed in various tissues of the body and is involved in the regulation of calcium ions in cells. Its functions include the regulation of cell growth, differentiation, and inflammation, as well as the regulation of the immune response and the production of antibodies. In addition, CELA2A has been suggested as a potential drug target or biomarker for a variety of diseases, including Alzheimer's disease and certain types of cancer. Further research is needed to fully understand its role and potential as a therapeutic agent.

Protein Name: Chymotrypsin Like Elastase 2A

Functions: Elastase that enhances insulin signaling and might have a physiologic role in cellular glucose metabolism. Circulates in plasma and reduces platelet hyperactivation, triggers both insulin secretion and degradation, and increases insulin sensitivity

The "CELA2A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CELA2A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets